×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Beam Therapeutics Inc. (BEAM) NASDAQ

$33.37 (0.60) (-1.75%)

Market Cap: $2.77B

As of 03/28/24 02:43 PM EDT. Market open.

(BEAM)

Beam Therapeutics Inc. (BEAM)
NASDAQ

$33.37
(0.60) (-1.75%)

Market Cap: $2.77B

As of 03/28/24 02:43 PM EDT. Market open.

Add to Portfolio

beam therapeutics is developing precision genetic medicines for serious diseases. co-founded by scientific pioneers known for advancing crispr gene editing, we’re the first company to pursue development of new therapies using crispr base editing technology. we aim to use these technologies to generate a broad pipeline of precision genetic medicines that repair disease-causing point mutations, ... read more

beam therapeutics is developing precision genetic medicines for serious diseases. co-founded by scientific pioneers known for advancing crispr gene editing, we’re the first company to pursue development of new therapies using crispr base editing technology. we aim to use these technologies to generate a broad pipeline of precision genetic medicines that repair disease-causing point mutations, write in protective genetic variations, or modulate the expression or function of disease-causing genes. who we are beam is creating precision genetic medicines through base editing why we do it our dream is to provide life-long cures for patients suffering from serious diseases who we are and how we work together the beam team: ? a community of fearless innovators ? rigorous and honest in our research ? listening with open minds ? committed to each other read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
John M. Evans
Full Time Employees
573
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
John M. Evans
Full Time Employees
573
Address
.
PRICE CHART FOR BEAM THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$34.04
Previous Close
$33.96
Days Range
$32.88 - $34.18
52 week range
$16.95 - $49.50
Volume
626,671
Avg. Volume (30 days)
1,299,561
Market Cap
$2.77B
Dividend Yield
-
P/E
(20.92)
Shares Outstanding
81,657,714
Open
$34.04
Previous Close
$33.96
Days Range
$32.88 - $34.18
52 week range
$16.95 - $49.50
Volume
626,671
Avg. Volume (30 days)
1,299,561
Market Cap
$2.77B
Dividend Yield
-
P/E
(20.92)
Shares Outstanding
81,657,714
FINANCIAL STATEMENTS FOR BEAM THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR BEAM THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
FMR LLCSee Remark 1Feb 14, 2024 Sale$30.55900,00027,496,9121,281,188Feb 15, 2024, 02:34 PM
FMR LLCSee Remark 1Feb 13, 2024 Sale$30.761,56548,1392,773,068Feb 15, 2024, 02:34 PM
Bellon ChristineChief Legal OfficerJan 03, 2024 Sale$26.421,90750,38380,495Jan 05, 2024, 04:30 PM
Bellon ChristineChief Legal OfficerNov 20, 2023 Option Exercise$7.2210,00072,20092,402Nov 22, 2023, 04:05 PM
Bellon ChristineChief Legal OfficerNov 20, 2023 Sale$30.5010,000305,00087,402Nov 22, 2023, 04:05 PM
Simon AmyChief Medical OfficerOct 30, 2023 Sale$18.703,44864,47865,469Nov 01, 2023, 04:30 PM
Ciaramella GiuseppePresident and CSOOct 20, 2023 Option Exercise$0.6790,90060,903139,150Oct 24, 2023, 04:05 PM
Bellon ChristineChief Legal OfficerOct 02, 2023 Sale$22.853888,86682,402Oct 04, 2023, 04:30 PM
Simon AmyChief Medical OfficerJul 10, 2023 Sale$30.4839111,91868,917Aug 09, 2023, 04:08 PM
Ciaramella GiuseppePresident and CSOJul 21, 2023 Option Exercise$7.2291,284659,070203,574Jul 25, 2023, 06:36 PM
Ciaramella GiuseppePresident and CSOJul 24, 2023 Option Exercise$7.221,2068,70749,456Jul 25, 2023, 06:36 PM
Ciaramella GiuseppePresident and CSOJul 24, 2023 Sale$32.011,20638,60448,250Jul 25, 2023, 06:36 PM
Ciaramella GiuseppePresident and CSOJul 21, 2023 Sale$32.06155,3244,979,68848,250Jul 25, 2023, 06:36 PM
Evans John M.CEOApr 04, 2023 Sale$29.096,493188,9041,117,979Apr 05, 2023, 08:30 PM
Evans John M.CEOApr 03, 2023 Sale$30.315,161156,4301,124,472Apr 05, 2023, 08:30 PM
Ciaramella GiuseppePresident & CSOApr 03, 2023 Sale$30.311,91858,135114,044Apr 05, 2023, 08:30 PM
Ciaramella GiuseppePresident & CSOApr 04, 2023 Sale$29.091,75451,029112,290Apr 05, 2023, 08:30 PM
Bellon ChristineChief Legal OfficerApr 04, 2023 Sale$29.091,16133,77782,790Apr 05, 2023, 08:30 PM
Bellon ChristineChief Legal OfficerApr 03, 2023 Sale$30.3193128,21983,951Apr 05, 2023, 08:30 PM
Simon AmyChief Medical OfficerApr 04, 2023 Sale$29.7011,654346,11570,469Apr 05, 2023, 08:30 PM
Simon AmyChief Medical OfficerApr 03, 2023 Sale$30.314,445134,72880,962Apr 05, 2023, 08:30 PM
Burrell Terry-AnnChief Financial OfficerApr 04, 2023 Sale$29.092,18663,59847,117Apr 05, 2023, 08:30 PM
Burrell Terry-AnnChief Financial OfficerApr 03, 2023 Sale$30.312,45474,38149,303Apr 05, 2023, 08:30 PM
Bellon ChristineChief Legal OfficerMar 30, 2023 Option Exercise$7.228,94164,55467,382Mar 31, 2023, 07:51 PM
Evans John M.CEOMar 31, 2023 Option Exercise$7.2213,85099,9971,129,153Mar 31, 2023, 07:48 PM
Burrell Terry-AnnChief Financial OfficerJan 27, 2023 Option Exercise$13.6836,152494,55967,429Jan 30, 2023, 04:05 PM
Burrell Terry-AnnChief Financial OfficerJan 26, 2023 Option Exercise$13.681,10215,07532,379Jan 30, 2023, 04:05 PM
Burrell Terry-AnnChief Financial OfficerJan 27, 2023 Sale$45.0836,1521,629,74731,277Jan 30, 2023, 04:05 PM
Burrell Terry-AnnChief Financial OfficerJan 26, 2023 Sale$45.161,10249,76331,277Jan 30, 2023, 04:05 PM
Burrell Terry-AnnChief Financial OfficerJan 24, 2023 Option Exercise$13.6814,810202,60146,087Jan 25, 2023, 05:25 PM
Burrell Terry-AnnChief Financial OfficerJan 23, 2023 Option Exercise$13.685,42674,22836,703Jan 25, 2023, 05:25 PM
Burrell Terry-AnnChief Financial OfficerJan 23, 2023 Sale$45.025,426244,29031,277Jan 25, 2023, 05:25 PM
Burrell Terry-AnnChief Financial OfficerJan 24, 2023 Sale$45.0114,810666,65731,277Jan 25, 2023, 05:25 PM
Burrell Terry-AnnChief Financial OfficerJan 18, 2023 Option Exercise$13.6839,886545,64078,472Jan 20, 2023, 04:18 PM
Burrell Terry-AnnChief Financial OfficerJan 18, 2023 Sale$45.1447,1952,130,38231,277Jan 20, 2023, 04:18 PM
Ciaramella GiuseppePresident & CSOJan 03, 2023 Option Exercise$0.9653,72951,356149,691Jan 05, 2023, 04:06 PM
Ciaramella GiuseppePresident & CSOJan 03, 2023 Sale$37.4653,7292,012,490112,166Jan 05, 2023, 04:06 PM
Ciaramella GiuseppePresident & CSODec 30, 2022 Option Exercise$0.674,5003,01595,962Jan 03, 2023, 04:31 PM
Ciaramella GiuseppePresident & CSODec 12, 2022 Option Exercise$1.8126,86348,713142,477Dec 14, 2022, 09:50 PM
Ciaramella GiuseppePresident & CSODec 12, 2022 Sale$42.7051,0152,178,229110,778Dec 14, 2022, 09:50 PM
Evans John M.CEOOct 31, 2022 Sale$46.3130,0001,389,2251,080,953Nov 02, 2022, 04:30 PM
Evans John M.CEOOct 31, 2022 Sale$46.3620,000927,203117,992Nov 02, 2022, 04:30 PM
FMR LLC10% OwnerSep 06, 2022 Sale$54.2555129,8920Sep 08, 2022, 11:04 AM
FMR LLC10% OwnerAug 05, 2022 Sale$60.5020,1591,219,6200Aug 08, 2022, 04:49 PM
FMR LLC10% OwnerAug 05, 2022 Sale$61.0016710,1870Aug 08, 2022, 04:49 PM
Evans John M.CEOJul 28, 2022 Sale$65.7820,0001,315,559136,047Jul 29, 2022, 04:06 PM
Evans John M.CEOJul 28, 2022 Sale$65.7530,0001,972,5231,108,339Jul 29, 2022, 04:06 PM
Evans John M.CEOApr 28, 2022 Option Exercise$2.3159,450137,0361,148,520May 02, 2022, 06:51 PM
Evans John M.CEOApr 28, 2022 Sale$37.9820,000759,597156,550May 02, 2022, 06:51 PM
Evans John M.CEOApr 28, 2022 Sale$37.9830,0001,139,3021,144,620May 02, 2022, 06:51 PM
FMR LLC10% OwnerApr 13, 2022 Sale$50.3918,803947,55712,004Apr 14, 2022, 05:13 PM
FMR LLC10% OwnerApr 13, 2022 Sale$50.7566333,6470Apr 14, 2022, 05:13 PM
Ciaramella GiuseppePresident & CSOMar 31, 2022 Sale$59.111,859109,885115,614Apr 04, 2022, 08:32 PM
Evans John M.CEOMar 31, 2022 Sale$59.116,261370,0881,089,070Apr 04, 2022, 08:27 PM
Burrell Terry-AnnCFOMar 31, 2022 Sale$59.111,787105,63038,278Apr 04, 2022, 08:22 PM
Evans John M.CEOJan 31, 2022 Option Exercise$1.03100,000103,0001,038,825Feb 02, 2022, 06:00 PM
Evans John M.CEOJan 31, 2022 Sale$66.8520,0001,337,088182,700Feb 02, 2022, 06:00 PM
Evans John M.CEOJan 31, 2022 Sale$66.8330,0002,004,815968,024Feb 02, 2022, 06:00 PM
Ciaramella GiuseppePresident & CSODec 29, 2021 Option Exercise$0.6739,70026,599102,473Dec 30, 2021, 06:00 PM
Ciaramella GiuseppePresident & CSODec 22, 2021 Option Exercise$7.222,60718,82365,380Dec 23, 2021, 06:00 PM
Ciaramella GiuseppePresident & CSODec 22, 2021 Sale$86.132,607224,53164,164Dec 23, 2021, 06:00 PM
Ciaramella GiuseppePresident & CSODec 21, 2021 Option Exercise$7.2225,104181,25187,877Dec 22, 2021, 06:00 PM
Ciaramella GiuseppePresident & CSODec 20, 2021 Option Exercise$7.224,28930,96767,062Dec 22, 2021, 06:00 PM
Ciaramella GiuseppePresident & CSODec 21, 2021 Sale$85.6925,1042,151,24971,421Dec 22, 2021, 06:00 PM
Ciaramella GiuseppePresident & CSODec 20, 2021 Sale$85.204,289365,42362,773Dec 22, 2021, 06:00 PM
Evans John M.CEOOct 06, 2021 Option Exercise$1.0327,70028,5311,061,225Oct 08, 2021, 04:21 PM
Evans John M.CEOOct 06, 2021 Sale$83.8027,7002,321,1981,058,076Oct 08, 2021, 04:21 PM
Evans John M.CEOOct 06, 2021 Sale$83.8020,0001,676,070200,829Oct 08, 2021, 04:21 PM
Ciaramella GiuseppePresident & CSOSep 17, 2021 Option Exercise$0.6718,01212,06862,773Sep 21, 2021, 06:00 PM
Evans John M.CEOAug 19, 2021 Option Exercise$1.0312,00012,3601,033,525Aug 20, 2021, 06:05 PM
Evans John M.CEOAug 19, 2021 Sale$99.4920,0001,989,744222,600Aug 20, 2021, 06:05 PM
COOPER GRAHAM KDirectorJul 06, 2021 Option Exercise$17.002,61444,4382,614Jul 08, 2021, 06:00 PM
COOPER GRAHAM KDirectorJul 06, 2021 Sale$120.612,614315,2632,000Jul 08, 2021, 06:00 PM
Evans John M.CEOJul 07, 2021 Option Exercise$1.0325,00025,7501,046,525Jul 08, 2021, 06:00 PM
Evans John M.CEOJul 07, 2021 Sale$107.8725,0002,696,8261,045,880Jul 08, 2021, 06:00 PM
Burrell Terry-AnnCFOJun 30, 2021 Option Exercise$13.6830,000410,40054,809Jul 02, 2021, 06:01 PM
Burrell Terry-AnnCFOJun 30, 2021 Sale$122.0030,0003,660,00039,809Jul 02, 2021, 06:01 PM
COOPER GRAHAM KDirectorJun 28, 2021 Option Exercise$17.0012,045204,76512,045Jun 30, 2021, 06:00 PM
COOPER GRAHAM KDirectorJun 28, 2021 Sale$106.3412,0451,280,8976,258Jun 30, 2021, 06:00 PM
Ciaramella GiuseppePresident & CSOJun 28, 2021 Option Exercise$17.0078,5801,335,860123,341Jun 30, 2021, 06:00 PM
Ciaramella GiuseppePresident & CSOJun 28, 2021 Sale$107.3578,5808,435,365120,936Jun 30, 2021, 06:00 PM
Burrell Terry-AnnCFOJun 28, 2021 Option Exercise$13.6845,000615,60069,809Jun 30, 2021, 06:00 PM
Burrell Terry-AnnCFOJun 28, 2021 Sale$107.6945,0004,846,01668,709Jun 30, 2021, 06:00 PM
Evans John M.CEOApr 23, 2021 Option Exercise$1.036,0006,1801,021,429Apr 23, 2021, 04:45 PM
Evans John M.CEOApr 21, 2021 Sale$70.4925,0001,762,2161,038,966Apr 23, 2021, 04:45 PM
Ciaramella GiuseppePresident & CSOMar 05, 2021 Option Exercise$0.674,0302,70019,761Apr 02, 2021, 05:13 PM
Burrell Terry-AnnCFOJan 04, 2021 Option Exercise$13.6825,000342,00032,309Jan 05, 2021, 05:40 PM
Burrell Terry-AnnCFOJan 04, 2021 Sale$81.7825,0002,044,48531,509Jan 05, 2021, 05:40 PM
Ciaramella GiuseppePresident & CSODec 30, 2020 Option Exercise$0.9555,84253,19747,573Jan 04, 2021, 05:32 PM
Ciaramella GiuseppePresident & CSODec 30, 2020 Sale$83.2643,8423,650,14445,274Jan 04, 2021, 05:32 PM
Evans John M.CEODec 30, 2020 Sale$84.9422,3001,894,125991,891Jan 04, 2021, 05:31 PM
Ciaramella GiuseppePresident & CSOSep 30, 2020 Option Exercise$0.673,7312,5003,731Oct 02, 2020, 05:49 PM
Burrell Terry-AnnCFOSep 18, 2020 Option Exercise$13.687,30999,9877,309Sep 21, 2020, 09:08 PM
Evans John M.CEOApr 16, 2020 Option Exercise$1.03115,000118,450993,257Aug 17, 2020, 09:25 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
FMR LLCSee Remark 102/14/202427,496,912
FMR LLCSee Remark 102/13/202448,139
Bellon ChristineChief Legal Officer01/03/202450,383
Bellon ChristineChief Legal Officer11/20/202372,200
Bellon ChristineChief Legal Officer11/20/2023305,000
Simon AmyChief Medical Officer10/30/202364,478
Ciaramella GiuseppePresident and CSO10/20/202360,903
Bellon ChristineChief Legal Officer10/02/20238,866
Simon AmyChief Medical Officer07/10/202311,918
Ciaramella GiuseppePresident and CSO07/21/2023659,070
Ciaramella GiuseppePresident and CSO07/24/20238,707
Ciaramella GiuseppePresident and CSO07/24/202338,604
Ciaramella GiuseppePresident and CSO07/21/20234,979,688
Evans John M.CEO04/04/2023188,904
Evans John M.CEO04/03/2023156,430
Ciaramella GiuseppePresident & CSO04/03/202358,135
Ciaramella GiuseppePresident & CSO04/04/202351,029
Bellon ChristineChief Legal Officer04/04/202333,777
Bellon ChristineChief Legal Officer04/03/202328,219
Simon AmyChief Medical Officer04/04/2023346,115
Simon AmyChief Medical Officer04/03/2023134,728
Burrell Terry-AnnChief Financial Officer04/04/202363,598
Burrell Terry-AnnChief Financial Officer04/03/202374,381
Bellon ChristineChief Legal Officer03/30/202364,554
Evans John M.CEO03/31/202399,997
Burrell Terry-AnnChief Financial Officer01/27/2023494,559
Burrell Terry-AnnChief Financial Officer01/26/202315,075
Burrell Terry-AnnChief Financial Officer01/27/20231,629,747
Burrell Terry-AnnChief Financial Officer01/26/202349,763
Burrell Terry-AnnChief Financial Officer01/24/2023202,601
Burrell Terry-AnnChief Financial Officer01/23/202374,228
Burrell Terry-AnnChief Financial Officer01/23/2023244,290
Burrell Terry-AnnChief Financial Officer01/24/2023666,657
Burrell Terry-AnnChief Financial Officer01/18/2023545,640
Burrell Terry-AnnChief Financial Officer01/18/20232,130,382
Ciaramella GiuseppePresident & CSO01/03/202351,356
Ciaramella GiuseppePresident & CSO01/03/20232,012,490
Ciaramella GiuseppePresident & CSO12/30/20223,015
Ciaramella GiuseppePresident & CSO12/12/202248,713
Ciaramella GiuseppePresident & CSO12/12/20222,178,229
Evans John M.CEO10/31/20221,389,225
Evans John M.CEO10/31/2022927,203
FMR LLC10% Owner09/06/202229,892
FMR LLC10% Owner08/05/20221,219,620
FMR LLC10% Owner08/05/202210,187
Evans John M.CEO07/28/20221,315,559
Evans John M.CEO07/28/20221,972,523
Evans John M.CEO04/28/2022137,036
Evans John M.CEO04/28/2022759,597
Evans John M.CEO04/28/20221,139,302
FMR LLC10% Owner04/13/2022947,557
FMR LLC10% Owner04/13/202233,647
Ciaramella GiuseppePresident & CSO03/31/2022109,885
Evans John M.CEO03/31/2022370,088
Burrell Terry-AnnCFO03/31/2022105,630
Evans John M.CEO01/31/2022103,000
Evans John M.CEO01/31/20221,337,088
Evans John M.CEO01/31/20222,004,815
Ciaramella GiuseppePresident & CSO12/29/202126,599
Ciaramella GiuseppePresident & CSO12/22/202118,823
Ciaramella GiuseppePresident & CSO12/22/2021224,531
Ciaramella GiuseppePresident & CSO12/21/2021181,251
Ciaramella GiuseppePresident & CSO12/20/202130,967
Ciaramella GiuseppePresident & CSO12/21/20212,151,249
Ciaramella GiuseppePresident & CSO12/20/2021365,423
Evans John M.CEO10/06/202128,531
Evans John M.CEO10/06/20212,321,198
Evans John M.CEO10/06/20211,676,070
Ciaramella GiuseppePresident & CSO09/17/202112,068
Evans John M.CEO08/19/202112,360
Evans John M.CEO08/19/20211,989,744
COOPER GRAHAM KDirector07/06/202144,438
COOPER GRAHAM KDirector07/06/2021315,263
Evans John M.CEO07/07/202125,750
Evans John M.CEO07/07/20212,696,826
Burrell Terry-AnnCFO06/30/2021410,400
Burrell Terry-AnnCFO06/30/20213,660,000
COOPER GRAHAM KDirector06/28/2021204,765
COOPER GRAHAM KDirector06/28/20211,280,897
Ciaramella GiuseppePresident & CSO06/28/20211,335,860
Ciaramella GiuseppePresident & CSO06/28/20218,435,365
Burrell Terry-AnnCFO06/28/2021615,600
Burrell Terry-AnnCFO06/28/20214,846,016
Evans John M.CEO04/23/20216,180
Evans John M.CEO04/21/20211,762,216
Ciaramella GiuseppePresident & CSO03/05/20212,700
Burrell Terry-AnnCFO01/04/2021342,000
Burrell Terry-AnnCFO01/04/20212,044,485
Ciaramella GiuseppePresident & CSO12/30/202053,197
Ciaramella GiuseppePresident & CSO12/30/20203,650,144
Evans John M.CEO12/30/20201,894,125
Ciaramella GiuseppePresident & CSO09/30/20202,500
Burrell Terry-AnnCFO09/18/202099,987
Evans John M.CEO04/16/2020118,450
Load More Insider Transactions
FUNDS WITH A POSITION IN BEAM THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ARK INVESTMENT MANAGEMENT LLC9,393,8891.51%6.94%Growth
BLACKROCK INC.6,662,0430.00462%2.14%Other
FARALLON CAPITAL MANAGEMENT LLC4,105,7530.55%-8.39%Event Driven, Value
GEODE CAPITAL MANAGEMENT, LLC1,575,2790.00449%7.25%Other
YIHENG CAPITAL MANAGEMENT, L.P.845,5001.33%50.85%Other
CANDRIAM S.C.A.212,6650.04%64.01%Other
MAGNETAR FINANCIAL LLC36,1720.02%ExitedEvent Driven, Other
CHANGE IN SHARES OUTSTANDING FOR BEAM THERAPEUTICS INC
STOCK BUYBACKS FOR BEAM THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
2.37%
1Q
12/31/2023
06/30/2023
5.98%
2Q
12/31/2023
03/31/2023
11.93%
3Q
12/31/2023
12/31/2022
14.29%
4Q
12/31/2023
09/30/2022
15.01%
5Q
12/31/2023
06/30/2022
15.22%
6Q
12/31/2023
03/31/2022
17.75%
7Q
12/31/2023
12/31/2021
18.92%
8Q
12/31/2023
09/30/2021
21.88%
9Q
12/31/2023
06/30/2021
30.04%
10Q
12/31/2023
03/31/2021
34.36%
11Q
12/31/2023
12/31/2020
73.11%
12Q
12/31/2023
09/30/2020
61.52%
13Q
12/31/2023
06/30/2020
63.66%
14Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
2.37%
1Q
06/30/2023
5.98%
2Q
03/31/2023
11.93%
3Q
12/31/2022
14.29%
4Q
09/30/2022
15.01%
5Q
06/30/2022
15.22%
6Q
03/31/2022
17.75%
7Q
12/31/2021
18.92%
8Q
09/30/2021
21.88%
9Q
06/30/2021
30.04%
10Q
03/31/2021
34.36%
11Q
12/31/2020
73.11%
12Q
09/30/2020
61.52%
13Q
06/30/2020
63.66%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR BEAM THERAPEUTICS INC
LOADING...